USC professors recieve NIH funding for clinical trial of Alzheimer’s drug
By Kukla Vera
USC Professors Roberta Diaz Brinton, PhD, of the USC School of Pharmacy and Lon Schneider, MD, MS, of the Keck School of Medicine of USC are principal investigators of a newly funded study from the National Institutes of Health, aimed at testing promising drugs for the prevention of Alzheimer’s disease.
The USC project, “Allopregnanolone Regenerative Therapeutic for MCI/Alzheimer’s: Dose Finding Phase 1,” is the first clinical trial to evaluate the safety and tolerability of using allopregnanolone (Allo), a natural brain steroid, in treating mild cognitive impairment and Alzheimer’s disease, as part of an intensified national effort to find effective interventions for the degenerative brain disease. … Read More »